10th Tumor Models For Combination Targeted Oncology Summit
12
Jul
-
14
Jul
2022
When
Boston
Massachusetts
USA
Where

From Leveraging Emerging Predictive Technologies to Engineering a Human-Physiologically Relevant Models – Deepen Our Understanding of Tumor Biology, Resistance Mechanisms & Dosing Strategy Following the success of KRAS, HER2, BCMA, drug developers have seen a new wave of novel, combination targeted oncology surging through pipeline.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

12 - 14 Jul 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Associate Director
Associate Director, Scientific Development
Chief Executive Officer
Senior Director, Tumor Biology
Senior Principal Scientist - Translational Immune Oncology
Associate Director, Immuno-Oncology

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Tempus Labs, Inc.

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data.

Biocytogen

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.

genOway

Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.

The Jackson Laboratory

Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.

Scientist.com

Scientist.com is the world’s largest marketplace for medical research. We help pharmaceutical scientists discover life-saving medicines in less time and at lower cost. Our mission is to make it possible to cure all human disease by 2050.

Nilogen Oncosystems

Nilogen Oncosystems is dedicated to streamlining and improving drug development in cancer and immuno-oncology.

Crown Bioscience

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.

INOVOTION

INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies.

Certis Oncology Solutions, Inc.

Certis began its journey in precision medicine, helping individual cancer patients and their oncologists determine--with certainty--the best available treatments for their unique cancers.

Hera BioLabs

Hera Biolabs is an innovative preclinical service and technology provider with novel gene-editing and rat model creation technologies.

Imagen Therapeutics

Imagen Therapeutics is a biotech company based in the UK, with an ongoing commitment to improving the outcomes of cancer patients by accelerating drug discovery and the development of new cancer therapies.

Kiyatec Inc.

Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins.

Studylog Systems, Inc

We have six company Core Values – Trust, Loyalty, Respect for Others, Honesty, Integrity, and Commitment – that capture our philosophy towards our people and customers.

Labcorp

Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers.

GemPharmatech

GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and anima

Organizer

Get emails from us

Thank you
Oops! Something went wrong